Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular Markers of Diabetic Retinopathy: Potential Screening Tool of the Future?

31 May 2016

Abstract excerpt

Diabetic retinopathy (DR) is among the leading causes of new onset blindness in adults. Effective treatment may delay the onset and progression of this disease provided it is diagnosed early. At present retinopathy can only be diagnosed via formal examination of the eye by a trained specialist, which limits the population that can be effectively screened. An easily accessible, reliable screening biomarker of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Glycation End Products research
Share to Retinal Diseases and Treatments
Share to Retinopathy of Prematurity Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27313539
DOI: 10.3389/fphys.2016.00200

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular Markers of Diabetic Retinopathy: Potential Screening Tool of the Future?PMID 27313539Read ↗

Circulating microRNA Biomarkers of Diabetic RetinopathySemantic proximity Read ↗

Advances and Perspectives in Relation to the Molecular Basis of Diabetic Retinopathy—A ReviewSemantic proximity Read ↗

A proposal for early and personalized treatment of diabetic retinopathy based on clinical pathophysiology and molecular phenotyping.Semantic proximity Read ↗

Advances in the Molecular Pathophysiology and Emerging Therapeutic Strategies for Diabetic RetinopathySemantic proximity Read ↗

Plasma miR-26a-5p is a biomarker for retinal neurodegeneration of early diabetic retinopathySemantic proximity Read ↗

Phenotypes and biomarkers of diabetic retinopathy.Semantic proximity Read ↗

Diabetic retinopathy: Proteomic approaches to help the differential diagnosis and to understand the underlying molecular mechanismsSemantic proximity Read ↗

Diabetic Retinopathy: New Treatment Approaches Targeting Redox and Immune MechanismsSemantic proximity Read ↗

[Diabetic retinopathy risk factors].Semantic proximity Read ↗

Exploring the Associated Genetic Causes of Diabetic Retinopathy as a Model of Inflammation in Retinal DiseasesSemantic proximity Read ↗

DNA methylation in diabetic retinopathy: pathogenetic role and potential therapeutic targetsSemantic proximity Read ↗

Remodeling of Retinal Architecture in Diabetic Retinopathy: Disruption of Ocular Physiology and Visual Functions by Inflammatory Gene Products and PyroptosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.